MaxCyte, Inc.MXCTNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P10
Near historical low
vs 5Y Ago
-1.5x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -15.20% |
| Q2 2025 | 6.20% |
| Q1 2025 | 27.94% |
| Q4 2024 | -13.21% |
| Q3 2024 | -5.39% |
| Q2 2024 | -15.86% |
| Q1 2024 | 14.31% |
| Q4 2023 | -6.74% |
| Q3 2023 | 10.59% |
| Q2 2023 | -6.33% |
| Q1 2023 | 5.57% |
| Q4 2022 | 7.57% |
| Q3 2022 | 13.40% |
| Q2 2022 | 24.72% |
| Q1 2022 | 11.37% |
| Q4 2021 | 21.85% |
| Q3 2021 | -13.44% |
| Q2 2021 | -47.25% |
| Q1 2021 | 24.22% |
| Q4 2020 | 8.27% |
| Q3 2020 | 10.45% |
| Q2 2020 | -3.64% |
| Q1 2020 | 7.62% |
| Q4 2019 | -0.23% |
| Q3 2019 | -18.45% |
| Q2 2019 | 0.00% |
| Q1 2019 | 53.13% |
| Q4 2018 | 0.00% |
| Q3 2018 | 28.88% |
| Q2 2018 | 0.00% |
| Q1 2018 | -30.73% |
| Q4 2017 | 0.00% |
| Q3 2017 | 69.16% |
| Q2 2017 | 0.00% |
| Q1 2017 | 58.60% |
| Q4 2016 | 0.00% |
| Q3 2016 | 28.77% |
| Q2 2016 | 0.00% |
| Q1 2016 | 30.89% |
| Q4 2015 | 0.00% |